These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28975182)

  • 41. Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
    Druce MR; Lewington V; Grossman AB
    Neuroendocrinology; 2010; 91(1):1-15. PubMed ID: 19590162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiopeptide imaging and therapy in Europe.
    Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
    J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
    de Jong M; Kwekkeboom D; Valkema R; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):463-9. PubMed ID: 12569416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer.
    Divgi C
    Semin Nucl Med; 2011 Sep; 41(5):369-73. PubMed ID: 21803187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
    Timmermand OV; Tran TA; Strand SE; Axelsson J
    J Nucl Med; 2015 Mar; 56(3):444-9. PubMed ID: 25655628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advances in radiation oncology.
    Elshaikh M; Ljungman M; Ten Haken R; Lichter AS
    Annu Rev Med; 2006; 57():19-31. PubMed ID: 16409134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proliferation and the advantage of longer-lived radionuclides in radioimmunotherapy.
    Howell RW; Goddu SM; Rao DV
    Med Phys; 1998 Jan; 25(1):37-42. PubMed ID: 9472824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radionuclide therapy of tumors: general aspects and considerations.
    Hoefnagel CA
    Int J Biol Markers; 1993; 8(3):172-9. PubMed ID: 8277209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Radionuclide therapy of malignant tumors].
    Altenbrunn HJ
    Z Gesamte Inn Med; 1978 Jul; 33(14):475-84. PubMed ID: 581247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use].
    Lundqvist H; Carlsson J; Gedda L; Tolmachev V; Garske U; Kairemo K
    Lakartidningen; 2004 Mar; 101(11):1000-2, 1005-6. PubMed ID: 15055121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
    Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
    PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerations.
    Sarnelli A; Guerriero F; Botta F; Ferrari M; Strigari L; Bodei L; D'Errico V; Grassi E; Fioroni F; Paganelli G; Orecchia R; Cremonesi M
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):216-231. PubMed ID: 26576734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential future application with therapeutic agents.
    Atkins HL
    Semin Nucl Med; 1979 Apr; 9(2):121-30. PubMed ID: 482948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of radionuclides in therapy].
    Vucina J; Han R
    Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outpatient therapeutic nuclear oncology.
    Turner JH
    Ann Nucl Med; 2012 May; 26(4):289-97. PubMed ID: 22222779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Technical advances in radiation therapy.
    Sause WT
    Urol Clin North Am; 1986 Aug; 13(3):501-23. PubMed ID: 3523928
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Criteria for the selection of radionuclides for targeting nuclear antigens for cancer radioimmunotherapy.
    Srivastava SC
    Cancer Biother Radiopharm; 1996 Feb; 11(1):43-50. PubMed ID: 10851519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
    Emfietzoglou D; Kostarelos K; Sgouros G
    J Nucl Med; 2001 Mar; 42(3):499-504. PubMed ID: 11337529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiopharmaceuticals in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A position paper from the International Society of Geriatric Oncology Task Force.
    Prior JO; Gillessen S; Wirth M; Dale W; Aapro M; Oyen WJG
    Eur J Cancer; 2017 May; 77():127-139. PubMed ID: 28391026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technological advances in radioimmunotherapy.
    Dearling JL; Pedley RB
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):457-69. PubMed ID: 17537620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.